Sex-related effectiveness of bivalirudin versus abciximab and heparin in non–ST-segment elevation myocardial infarction

Conclusion: Despite a higher peri-PCI bleeding risk in women, bivalirudin is as effective as and safer than abciximab plus heparin in women and men with NSTEMI undergoing PCI.

Source: American Heart Journal - February 20, 2013 Category: Cardiology Authors: Julinda Mehilli, Franz-Josef Neumann, Gjin Ndrepepa, Lamin King, Stefanie Schulz, Fatima Maimer Rodrigues da Cunha, David Jochheim, Robert A. Byrne, Jörg Hausleiter, Ilka Ott, Steffen Massberg, Adnan Kastrati, Jürgen Pache Tags: Acute Ischemic Heart Disease Source Type: research